Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhone Ma Holdings BhdXKLS:5278 61 ROC (Joel Greenblatt) % is 13.34% as of Mar. 2026, which is 2% below its 10-year median of 13.68. GuruFocus rates XKLS:5278 with a GF Score™ of 61/100 and a GF Value™ of RM0.91 (Modestly Undervalued). Among 981 Drug Manufacturers companies, Rhone Ma Holdings Bhd ranks better than 56.88% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Rhone Ma Holdings Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 13.34%.
The historical rank and industry rank for Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) % or its related term are showing as below:
XKLS:5278'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 10.33 Med: 13.68 Max: 27.12
Current: 15.04
During the past 13 years, Rhone Ma Holdings Bhd's highest ROC (Joel Greenblatt) % was 27.12%. The lowest was 10.33%. And the median was 13.68%.
XKLS:5278's ROC (Joel Greenblatt) % is ranked better than 56.88% of 981
companies
in the Drug Manufacturers industry
Industry Median: 11.46
vs XKLS:5278: 15.04
Rhone Ma Holdings Bhd's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 2.70% per year.
Rhone Ma Holdings Bhd (XKLS:5278) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Rhone Ma Holdings Bhd ROC (Joel Greenblatt) % Related Terms
Rhone Ma Holdings Bhd ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhone Ma Holdings Bhd ROC (Joel Greenblatt) % Chart
XKLS:5278 vs ZTS, UTHR, VTRS: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhone Ma Holdings Bhd ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) % falls into.
Rhone Ma Holdings Bhd ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 13.34% mean?
Rhone Ma Holdings Bhd (XKLS:5278) has a ROC (Joel Greenblatt) % of 13.34% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Rhone Ma Holdings Bhd and its competitors. This is near median its historical median of 13.68. Over the past decade, Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) % has ranged from 10.33 to 27.12. According to the industry distribution chart, Rhone Ma Holdings Bhd ranks #423 out of 981 companies in the Drug Manufacturers industry, placing it in the top 43.1%.
Is Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) % too high?
Rhone Ma Holdings Bhd's current ROC (Joel Greenblatt) % of 13.34% is near median its 10-year median of 13.68. Over the past 10 years, this metric has ranged from a low of 10.33 to a high of 27.12. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.46. Rhone Ma Holdings Bhd's value of 13.34% is 16.4% above this industry median. Based on the distribution chart, Rhone Ma Holdings Bhd ranks #423 out of 981 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Rhone Ma Holdings Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rhone Ma Holdings Bhd's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rhone Ma Holdings Bhd ranks #423 out of 981 companies for ROC (Joel Greenblatt) %. This puts Rhone Ma Holdings Bhd in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 11.46. Rhone Ma Holdings Bhd's value of 13.34% is 16.4% above this benchmark. Historically, Rhone Ma Holdings Bhd's own ROC (Joel Greenblatt) % has ranged from 10.33 to 27.12 over the past decade. While the company's 10-year median is 13.68 vs. the industry median of 11.46, Rhone Ma Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.46, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhone Ma Holdings Bhd's current ROC (Joel Greenblatt) % of 13.34% is 16.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Rhone Ma Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhone Ma Holdings Bhd's current ROC (Joel Greenblatt) % is 13.34%, which is near median its own 10-year median of 13.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhone Ma Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd (XKLS:5278) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.91, compared to a current price of RM0.70 — trading 23.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is 13.34%, which is near median its 10-year median of 13.68 and 16.4% above the Drug Manufacturers industry median of 11.46. Rhone Ma Holdings Bhd's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Rhone Ma Holdings Bhd (XKLS:5278), the current ROC (Joel Greenblatt) % is 13.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhone Ma Holdings Bhd (XKLS:5278) Overvalued in 2026?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.70 is trading 23.1% below its estimated GF Value™ of RM0.91.
GuruFocus considers Rhone Ma Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:5278:
ROC (Joel Greenblatt) %: 13.34% (near median its 10-year median of 13.68)
GF Value™: RM0.91 vs. price of RM0.70 (23.1% below fair value)
Industry Position: 16.4% above the Drug Manufacturers median (#423 of 981)
No single metric tells the full story. See the XKLS:5278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhone Ma Holdings Bhd, along with its subsidiaries, is mainly involved in the provision of end-to-end animal health solutions. The Group provides veterinary consultation services, diagnostic laboratory analyses, R&D, and is engaged in the manufacturing and distribution of animal health products. Its reportable segments are: Animal health products and equipment, Food ingredients, and Others. The majority of its revenue is generated from the Animal health products and equipment segment, which is engaged in marketing, trading, distribution, and manufacturing of animal health products and equipment, such as pharmaceuticals, vaccines, feed additives, pesticides, and others. Geographically, the Group's operations are predominantly located in Malaysia.
61GF Score
Get the complete analysis for XKLS:5278
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5278 has been successfully added to your 
